001     62864
005     20200402210514.0
024 7 _ |2 pmid
|a pmid:18473442
024 7 _ |2 DOI
|a 10.1021/bi800253c
024 7 _ |2 WOS
|a WOS:000256405800020
037 _ _ |a PreJuSER-62864
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biochemistry & Molecular Biology
100 1 _ |a Leliveld, S. R.
|b 0
|u FZJ
|0 P:(DE-Juel1)VDB72260
245 _ _ |a Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein
260 _ _ |a Columbus, Ohio
|b American Chemical Society
|c 2008
300 _ _ |a 6267 - 6278
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Biochemistry
|x 0006-2960
|0 798
|y 23
|v 47
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a A misfolded conformation of the prion protein (PrP), PrP (Sc), is the essential component of prions, the infectious agents that cause transmissible neurodegenerative diseases. Insertional mutations that lead to an increase in the number of octarepeats (ORs) in PrP are linked to familial human prion disease. In this study, we investigated how expansion of the OR domain causes PrP to favor a prion-like conformation. Therefore, we compared the conformational and aggregation modulating properties of wild-type versus expanded OR domains, either as a fusion construct with the protein G B1 domain (GB1-OR) or as an integral part of full-length mouse PrP (MoPrP). Using circular dichroism spectroscopy, we first demonstrated that ORs are not unfolded but exist as an ensemble of three distinct conformers: polyproline helix-like, beta-turn, and "Trp-related". Domain expansion had little effect on the conformation of GB1-OR fusion proteins. When part of MoPrP however, OR domain expansion changed PrP's folding landscape, not by hampering the production of native alpha-helical monomers but by greatly reducing the propensity to form amyloid and by altering the assembly of misfolded, beta-rich aggregates. These features may relate to subtle pH-dependent conformational differences between wild-type and mutant monomers. In conclusion, we propose that PrP insertional mutations are pathogenic because they enhance specific misfolding pathways of PrP rather than by undermining native folding. This idea was supported by a trial bioassay in transgenic mice overexpressing wild-type MoPrP, where intracerebral injection of recombinant MoPrP with an expanded OR domain but not wild-type MoPrP caused prion disease.
536 _ _ |a Funktion und Dysfunktion des Nervensystems
|c P33
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK409
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Animals
650 _ 2 |2 MeSH
|a Circular Dichroism
650 _ 2 |2 MeSH
|a Kinetics
650 _ 2 |2 MeSH
|a Mice
650 _ 2 |2 MeSH
|a Mutagenesis, Insertional
650 _ 2 |2 MeSH
|a Open Reading Frames
650 _ 2 |2 MeSH
|a PrPSc Proteins: chemistry
650 _ 2 |2 MeSH
|a PrPSc Proteins: genetics
650 _ 2 |2 MeSH
|a PrPSc Proteins: metabolism
650 _ 2 |2 MeSH
|a Prions: chemistry
650 _ 2 |2 MeSH
|a Prions: genetics
650 _ 2 |2 MeSH
|a Prions: metabolism
650 _ 2 |2 MeSH
|a Protein Conformation
650 _ 2 |2 MeSH
|a Protein Denaturation
650 _ 2 |2 MeSH
|a Protein Folding
650 _ 2 |2 MeSH
|a Recombinant Proteins: chemistry
650 _ 2 |2 MeSH
|a Repetitive Sequences, Amino Acid
650 _ 2 |2 MeSH
|a Thrombin
650 _ 7 |0 0
|2 NLM Chemicals
|a PrPSc Proteins
650 _ 7 |0 0
|2 NLM Chemicals
|a Prions
650 _ 7 |0 0
|2 NLM Chemicals
|a Recombinant Proteins
650 _ 7 |0 EC 3.4.21.5
|2 NLM Chemicals
|a Thrombin
650 _ 7 |a J
|2 WoSType
700 1 _ |a Stitz, L.
|b 1
|0 P:(DE-HGF)0
700 1 _ |a Korth, C.
|b 2
|u FZJ
|0 P:(DE-Juel1)VDB72259
773 _ _ |a 10.1021/bi800253c
|g Vol. 47, p. 6267 - 6278
|p 6267 - 6278
|q 47<6267 - 6278
|0 PERI:(DE-600)1472258-6
|t Biochemistry
|v 47
|y 2008
|x 0006-2960
856 7 _ |u http://dx.doi.org/10.1021/bi800253c
909 C O |o oai:juser.fz-juelich.de:62864
|p VDB
913 1 _ |k P33
|v Funktion und Dysfunktion des Nervensystems
|l Funktion und Dysfunktion des Nervensystems
|b Gesundheit
|0 G:(DE-Juel1)FUEK409
|x 0
914 1 _ |y 2008
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k INB-2
|l Molekulare Biophysik
|d 31.12.2008
|g INB
|0 I:(DE-Juel1)VDB805
|x 0
970 _ _ |a VDB:(DE-Juel1)99747
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ISB-2-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ISB-2-20090406
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21